SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

Share Price is delayed by 15 minutes
Get Live Data
73.50    0.50 (0.68%)
Bid:
72.00
Ask:
75.00
Spread: 3.00 (4.167%)
Market Cap: £306.68m
BSV Live PriceLast checked at - London Stock Exchange

Intraday Br.smaller Cos. Share Chart

Interim Management Statement

23 Feb 2018 09:06

RNS Number : 7741F
British Smaller Companies VCT PLC
23 February 2018
 

 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 31 December 2017

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 31 December 2017. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company has continued to make good progress with total return rising to 214.8 pence per ordinary share; Net Asset Value ("NAV") stood at 78.4 pence per ordinary share. This is an increase of 1.4 pence per ordinary share in the quarter equivalent to 1.8% growth in the period.

Performance

31 December 2017

Movement

30 September 2017

Net Assets (£m)

85.1

1.1

84.0

NAV per share (PPS)

78.4p

1.4p

77.0p

Cumulative dividends paid (PPS)

136.4p

-

136.4p

Total Return (PPS)

214.8p

1.4p

213.4p

Shares in issue

108,607,183

(500,000)

109,107,183

 

The total return at 31 December 2017, calculated by reference to the NAV per ordinary share and the cumulative dividends paid per ordinary share, was 214.8 pence per ordinary share compared to 213.4 pence per ordinary share at 30 September 2017.

The unaudited NAV per ordinary share as at 31 December 2017 was 78.4p pence per ordinary share (30 September 2017: 77.0 pence per ordinary share). Cumulative dividends paid were unchanged at 136.4 pence per ordinary share (30 September 2017: 136.4 pence per ordinary share).

Shares in issue

On 19 December 2017 the Company purchased 500,000 ordinary shares of 10 pence each at a price of 73.65 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 31 December 2017 was 108,607,183 (30 September 2017: 109,107,183). In addition, at 31 December 2017 the Company held 4,807,999 ordinary shares in treasury (30 September 2017: 4,307,999).

Net assets

Net assets at 31 December 2017 comprised the following:

£000

% of net assets

Unquoted investments at fair value

54,459

64.0

Quoted investments at bid price

2,205

2.6

Total investments

56,664

66.6

Fixed income government securities

708

0.8

Quoted funds

1,893

2.2

Cash and cash equivalents

24,378

28.6

Other net current assets

1,477

1.8

Net assets

85,120

100.0

 

The investment portfolio at 31 December 2017 was comprised as follows:

Valuation

£000

Valuation as a % of net assets

Intelligent Office

 4,960

5.8

ACC Aviation

 4,672

5.5

Mangar Health Limited

 3,962

4.7

GTK (Holdco) Limited

 2,964

3.5

Springboard Research Holdings Limited

 2,896

3.4

Matillion Limited

2,728

3.2

Business Collaborator Limited

 2,703

3.2

Gill Marine Holdings Limited

 2,569

3.0

Deep-Secure Limited

 2,550

3.0

KeTech Enterprises Limited

2,336

2.7

32,340

38.0

Other investments

24,324

28.6

Total investments

56,664

66.6

 

There were no investments during the period.

In the quarter to 31 December 2017 the realisation and repayment of investments generated proceeds of £1.4 million.

 

Portfolio Performance

Over the quarter to 31 December 2017 aggregate unrealised portfolio valuations have increased by £1.6 million. There were strong performances in the quarter from the investments in GTK, Matillion, Deep-Secure and Business Collaborator, offset by reductions from RMS, Sipsynergy and DisplayPlan.

The Board continues to follow its policy of maintaining a diversified portfolio. At 31 December 2017, only two investments represented more than 5 per cent of the Company's NAV.

Outlook

Your Board remains encouraged by the increase in investment opportunities that it is seeing, although the conversion of this pipeline to new investments continues to be hampered by the slow granting of advance assurance from HMRC. The Company has just received advance assurances for two new investments (£3.3 million) which it is hoped will complete in the near future, and is awaiting assurance on one further investment of £1.3 million.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

 

23 February 2018

 

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Jonathan Becher Panmure Gordon (UK) Limited Tel: 0207 886 2715

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTPGUCUPUPRUBW
Date   Source Headline
11th Jun 202612:15 pmRNSAnnual Financial Report
20th Apr 202610:00 amRNSAdmission to Trading
1st Apr 20269:00 amRNSIssue of Equity
27th Mar 20264:10 pmRNSTransaction in Own Shares
23rd Mar 202610:45 amRNSPublication of a Supplementary Prospectus
19th Mar 20267:00 amRNS3rd Quarter Results
30th Jan 20267:00 amRNSAdmission of Further Securities to Trading
7th Jan 20269:30 amRNSIssue of Equity
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
22nd Dec 20259:13 amRNSTransaction in Own Shares
22nd Dec 20259:13 amRNSTransaction in Own Shares
19th Dec 202510:02 amRNSPayment of Dividend and Issue of Equity
19th Dec 202510:02 amRNSPayment of Dividend and Issue of Equity
18th Dec 202512:14 pmRNSClose of Offers to new Applications
18th Dec 202512:14 pmRNSClose of Offers to new Applications
28th Nov 202510:00 amRNSHalf-year Financial Report
20th Nov 20259:00 amRNSOffer Update
11th Nov 20257:00 amRNSDividend Declaration
27th Oct 202511:00 amRNSNominal Capital Reduction
10th Oct 20253:41 pmRNSOffer Update
2nd Oct 20259:00 amRNSOffer Update
25th Sep 20259:04 amRNSPublication of a Prospectus
23rd Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSInterim Management Statement
9th Sep 202512:56 pmRNSResult of AGM
22nd Aug 202510:45 amRNSNew combined offer for subscription
25th Jul 202510:16 amRNSPayment of dividend and issue of Equity
24th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20251:30 pmRNSAnnual Financial Report
1st Apr 20258:02 amRNSDirector/PDMR Shareholding
1st Apr 20258:00 amRNSIssue of Equity
26th Mar 20255:13 pmRNSTransaction in Own Shares
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
18th Mar 20251:00 pmRNS3rd Quarter Results
30th Jan 20259:05 amRNSDirector/PDMR Shareholding
30th Jan 20259:00 amRNSIssue of Equity
27th Jan 20259:23 amRNSPayment of dividend and issue of shares
8th Jan 20252:14 pmRNSClose of Offer to new Applications
8th Jan 20252:13 pmRNSClose of Offer to new Applications
20th Dec 20249:26 amRNSPayment of dividend and issue of equity
17th Dec 20247:00 amRNSDividend Declaration
16th Dec 20245:09 pmRNSTransaction in Own Shares
29th Nov 20249:00 amRNSHalf-year Report
20th Nov 20241:00 pmRNSOffer Update
20th Nov 20241:00 pmRNSOffer Update
14th Nov 20247:48 amRNSDividend Declaration
1st Nov 20247:00 amRNSOffer Update
1st Nov 20247:00 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.